These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 32506725)

  • 61. Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19).
    Shanmugaraj B; Siriwattananon K; Wangkanont K; Phoolcharoen W
    Asian Pac J Allergy Immunol; 2020 Mar; 38(1):10-18. PubMed ID: 32134278
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Serological differentiation between COVID-19 and SARS infections.
    Chia WN; Tan CW; Foo R; Kang AEZ; Peng Y; Sivalingam V; Tiu C; Ong XM; Zhu F; Young BE; Chen MI; Tan YJ; Lye DC; Anderson DE; Wang LF
    Emerg Microbes Infect; 2020 Dec; 9(1):1497-1505. PubMed ID: 32529906
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Susceptibility of the Elderly to SARS-CoV-2 Infection: ACE-2 Overexpression, Shedding, and Antibody-dependent Enhancement (ADE).
    Peron JPS; Nakaya H
    Clinics (Sao Paulo); 2020; 75():e1912. PubMed ID: 32428113
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Perspectives on development of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
    Zhang C; Zhou C; Shi L; Liu G
    Hum Vaccin Immunother; 2020 Oct; 16(10):2366-2369. PubMed ID: 32961082
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Characteristics and serological patterns of COVID-19 convalescent plasma donors: optimal donors and timing of donation.
    Li L; Tong X; Chen H; He R; Lv Q; Yang R; Zhao L; Wang J; Xu H; Liu C; Chen G; Chen S; Li C; Qiao J; Yang J; Wu Y; Liu Z
    Transfusion; 2020 Aug; 60(8):1765-1772. PubMed ID: 32627216
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.
    McAndrews KM; Dowlatshahi DP; Dai J; Becker LM; Hensel J; Snowden LM; Leveille JM; Brunner MR; Holden KW; Hopkins NS; Harris AM; Kumpati J; Whitt MA; Lee JJ; Ostrosky-Zeichner LL; Papanna R; LeBleu VS; Allison JP; Kalluri R
    JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32796155
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2.
    Chi X; Yan R; Zhang J; Zhang G; Zhang Y; Hao M; Zhang Z; Fan P; Dong Y; Yang Y; Chen Z; Guo Y; Zhang J; Li Y; Song X; Chen Y; Xia L; Fu L; Hou L; Xu J; Yu C; Li J; Zhou Q; Chen W
    Science; 2020 Aug; 369(6504):650-655. PubMed ID: 32571838
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Is COVID-19 receiving ADE from other coronaviruses?
    Tetro JA
    Microbes Infect; 2020 Mar; 22(2):72-73. PubMed ID: 32092539
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification of potential cross-protective epitope between a new type of coronavirus (2019-nCoV) and severe acute respiratory syndrome virus.
    Qiu T; Mao T; Wang Y; Zhou M; Qiu J; Wang J; Xu J; Cao Z
    J Genet Genomics; 2020 Feb; 47(2):115-117. PubMed ID: 32171450
    [No Abstract]   [Full Text] [Related]  

  • 70. ADE and hyperinflammation in SARS-CoV2 infection- comparison with dengue hemorrhagic fever and feline infectious peritonitis.
    Cloutier M; Nandi M; Ihsan AU; Chamard HA; Ilangumaran S; Ramanathan S
    Cytokine; 2020 Dec; 136():155256. PubMed ID: 32866898
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Fruitful Neutralizing Antibody Pipeline Brings Hope To Defeat SARS-Cov-2.
    Renn A; Fu Y; Hu X; Hall MD; Simeonov A
    Trends Pharmacol Sci; 2020 Nov; 41(11):815-829. PubMed ID: 32829936
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19.
    Karthik K; Senthilkumar TMA; Udhayavel S; Raj GD
    Hum Vaccin Immunother; 2020 Dec; 16(12):3055-3060. PubMed ID: 32845733
    [TBL] [Abstract][Full Text] [Related]  

  • 73. COVID-19 Vaccines: Should We Fear ADE?
    Halstead SB; Katzelnick L
    J Infect Dis; 2020 Nov; 222(12):1946-1950. PubMed ID: 32785649
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Currently available intravenous immunoglobulin contains antibodies reacting against severe acute respiratory syndrome coronavirus 2 antigens.
    Díez JM; Romero C; Gajardo R
    Immunotherapy; 2020 Jun; 12(8):571-576. PubMed ID: 32397847
    [No Abstract]   [Full Text] [Related]  

  • 75. Theoretical Explanation for the Rarity of Antibody-Dependent Enhancement of Infection (ADE) in COVID-19.
    Boldova AE; Korobkin JD; Nechipurenko YD; Sveshnikova AN
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232664
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Need for Speed: From Human SARS-CoV-2 Samples to Protective and Efficacious Antibodies in Weeks.
    Joyce MG; Wheatley AK; Modjarrad K
    Cell; 2020 Jul; 182(1):7-9. PubMed ID: 32649880
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Insights into coronavirus immunity taught by the murine coronavirus.
    Grabherr S; Ludewig B; Pikor NB
    Eur J Immunol; 2021 May; 51(5):1062-1070. PubMed ID: 33687066
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV.
    Zheng M; Song L
    Cell Mol Immunol; 2020 May; 17(5):536-538. PubMed ID: 32132669
    [No Abstract]   [Full Text] [Related]  

  • 79. COVID-19 with dengue shock syndrome in a child: coinfection or cross-reactivity?
    Tiwari L; Shekhar S; Bansal A; Kumar P
    BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33370956
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antibodies Capable of Enhancing SARS-CoV-2 Infection Can Circulate in Patients with Severe COVID-19.
    Matveev A; Pyankov O; Khlusevich Y; Tyazhelkova O; Emelyanova L; Timofeeva A; Shipovalov A; Chechushkov A; Zaitseva N; Kudrov G; Yusubalieva G; Yussubaliyeva S; Zhukova O; Baklaushev V; Sedykh S; Lifshits G; Tikunov A; Tikunova N
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.